Results 301 to 310 of about 306,098 (388)
Objective Ultrasound (US) has been proposed as a potential tool for assessing skin fibrosis in systemic sclerosis (SSc). However, a large‐scale comparison of US‐based assessment with histologic markers of skin fibrosis has not been reported. We evaluated US‐based skin assessments for their face validity (differentiation between involved SSc and healthy
Ruhani Desai +12 more
wiley +1 more source
Long-Term Safety Evaluations in the Presence of Switching: Evaluation of Two Approaches. [PDF]
Schmeller S, Izem R, Romero PL, Jehl V.
europepmc +1 more source
Revised and updated estimates of the net cost of implementing the therapy in a target health care system using data produced from the whole programme of work.
openaire +1 more source
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech +4 more
wiley +1 more source
A Corrected Score Approach for Proportional Hazards Model With Error-Contaminated Covariates Subject to Detection Limits. [PDF]
Song X, Wang CY.
europepmc +1 more source
Path Analysis With Mixed-Scale Variables: Categorical ML, Least Squares, and Bayesian Estimations. [PDF]
Liang X, Castro P, Cao C, Lo WJ.
europepmc +1 more source
Difference-in-differences analysis with repeated cross-sectional survey data. [PDF]
Ye K, Bilinski A, Lee Y.
europepmc +1 more source
The Wilcoxon-Mann-Whitney Estimand Versus Differences in Medians or Means. [PDF]
Harrison LJ, Bosch RJ.
europepmc +1 more source
New capture-recapture models of behavioral response for estimating the size of a closed animal population. [PDF]
Zhang Y, Lyles RH.
europepmc +1 more source

